MEETINGS - Joint Economic Committee of the US Congress holds Research and Development Fair (US) September 1999:
This article was originally published in Clinica
Executive Summary
The Joint Economic Committee of the US Congress will hold a Research and Development Fair on September 29 in the Senate Office Building in Washington, DC, to showcase some of the latest breakthroughs in medical technology. Participating companies include Advanced Bionics, Biopure, Boston Scientific, CR Bard, Coherent, Cytometrics, Guidant, Hewlett-Packard, Integra LifeSciences, KeraVision, Medtronic, MicroMed Technology and NeuroControl. The fair is being held in conjunction with a one-day summit exploring the effects biotechnology has on the economy. For more information contact the committee. Tel: +1 202 224 5171.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.